Furthermore, we identified a small-molecule IGF2BP2 inhibitor JX5 and treatment of T-ALL with JX5 showed similar functions as knockdown of IGF2BP2. The gene discussed is IGF2BP2; the disease is acute lymphoblastic leukemia.